Efficacy of Immunoglobulin and Prednisolone in Diabetic Amyotrophy [1]

Endocrine Journal

Volumn 50, Issue 6, 2003, Pages 831-832

  Morii, Tsukasa ^a   Fujita, Hiroki ^a   Toyoshima, Itaru ^a   Sageshima, Masato ^a   Ito, Seiki ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; IMMUNOGLOBULIN; MECOBALAMIN; PREDNISOLONE;

ADULT; CASE REPORT; DIABETIC AMYOTROPHY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME;

ADULT; DIABETIC NEUROPATHIES; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS; MALE; PREDNISOLONE; TREATMENT OUTCOME;

EID: 0942298673     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.831     Document Type: Letter

References (5)

1. O'Harre JA (1994) Prevalence and forms of neuropathic morbidity in 800 diabetes. Ir J Med Sci 163: 132-135.
2. Bruns L (1890) Ueber neuritsche Lahmungen beim diabetes mellitus. Berlin Klin Wochenscher 27: 509.
3. Dyck PJB, Windebank AJ (2002) Diabetic and non-diabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 25: 477-491.
4. Krendel DA, Costigan DA, Hopkins LC (1995) Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 52: 1053-1061.
5. Ogawa T, Taguchi T, Tanaka Y, Ikeguchi K, Nakano I (2001) Intravenous immunoglobulin therapy for diabetic amyotrophy. Intern Med 40: 349-352.